The event, to be held at Binario F – Via Marsala 29H, Rome, will bring together representatives from research, institutions, innovation and business to discuss new opportunities in the life sciences and the development of the biotech ecosystem.
The first part of the event, from 16:00 to 17:00, will be dedicated to the presentation of the book “Mangia Italiano ma fallo bene”, published by Edizioni Palinsesto in 2026. The authors taking part will be Michele Ciro Pistillo, Augusto Orsini, Patrizia Lusi, Matteo Russo and Salvatore Venosi.
From 17:00 to 19:00 the programme will feature the presentation of the International Biotech Academy, followed by a discussion with professionals and experts from scientific, academic, institutional and business organisations.
Speakers will include Maurizio Andolfi, Head of the Spazio Attivo and Open Innovation Service at Lazio Innova; Massimo Calzoni, Head of Promotion and Sistema Invitalia Startup; Cinzia Ciacia, sociologist and lecturer at Tor Vergata University; Aldo De Simone, President, Pharmafuture; Stefano Di Rosa, Director General, Technoscience; Andrea Frustaci, Head of the Cellular and Molecular Cardiology Laboratory at IRCCS Lazzaro Spallanzani in Rome; Maurizio Giummarra, Public Sector Account Manager at Digit’Ed; and Roberto Panzarani, President, Studio Panzarani & Associates.
Also taking part will be Michele Pierangeli, Chief Innovation Officer – CINO, Synergo Srl; Matteo Russo, Head of Preclinical Research, IRCCS San Raffaele; Lorenzo Sgarro, member of the Technoscience Board of Directors; Davide Taschetti, Private Banker at Fideuram – Intesa Sanpaolo; Angelo Vescovi, Professor of Cell Biology and Senior Scientific Researcher at the Abu Dhabi Stem Cells Center; and Giovanni Zappia, a technology transfer expert in life sciences projects.
The event will be coordinated by Felice Paolo Arcuri, CEO of S3 Opus, serving as chairman.
During the event, an Invitalia Info Point will also be available for startups, researchers and companies, providing information on incentives, funding and support services for the creation and development of new business ventures.
Biotech Generation will therefore provide an opportunity for people with different areas of expertise to connect scientific research, innovation, technology transfer and new business ventures in the life sciences sector.
Biotech Generation
Research, innovation, training and business come together in Rome for a day dedicated to new perspectives in the life sciences.
Biotech Generation brings together representatives from research, institutions, innovation and business for a discussion on the development of the biotech ecosystem and the life sciences.
The event will take place on 21 September from 16:00 to 19:00 at Binario F, Via Marsala 29H, Rome, as part of Rome Future Week.
Two sessions, one shared journey
Presentation of the book
“Mangia Italiano ma fallo bene”, Edizioni Palinsesto 2026, with authors Michele Ciro Pistillo, Augusto Orsini, Patrizia Lusi, Matteo Russo and Salvatore Venosi.
International Biotech Academy
Presentation of the International Biotech Academy and a discussion with professionals and experts from research, innovation, institutions and business.
The key figures at Biotech Generation
Invitalia Info Point
During Biotech Generation, an Invitalia Info Point will be available, Invitalia Info Point dedicated to startups, researchers and companies: an opportunity to learn about incentives, funding and support services for the creation and development of new business ventures.
Biotech Generation
21 September 2026 · 16:00 – 19:00
Binario F – Rome, Via Marsala 29H
How we turn ideas into biotech projects
Would you like to understand how we could work together on complex biotech projects, such as the one on glioblastoma? Below is a selection of in-depth pages on biopharmaceutical pipelines, biobanks, data management and AI, telemedicine, precision cardiology and TRL pathways. They are the starting point for turning a good idea into an operational pathway, from the initial concept through to clinical validation and market entry.
Careers & Skills
Industry & Technology Transfer
GREEN & AGRI-BIOTECH
Biopharmaceuticals & Therapies
Biotechnology for Health
Frequently Asked Questions
Biotech FAQ
The questions you ask us most often
It is an approach that defines the the actual biology of the disease (tissues, markers and omics profiles where indicated) and links it to diagnostic and therapeutic decisions diagnostic and therapeutic personalised. It does not stop at generic classifications or guidelines applied wholesale: it builds a individual pathway measurable through robust clinical endpoints.
An enabling role. The biobanks ensure traceable and comparable samples; the omics broaden the understanding of the underlying mechanisms (inflammatory, metabolic and genetic). When integrated with rigorous protocols and real-world data, make reproducible the evidence and accelerate translation towards clinical trials or clinical adoption.
